EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
22 hedge funds and large institutions have $731K invested in Eucrates Biomedical Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.25K | |
| 2 | +$1.14K | |
| 3 | +$736 | |
| 4 |
CS
Clear Street
New York
|
+$107 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$7 |
Top Sellers
| 1 | -$7.08K | |
| 2 | -$1.75K | |
| 3 | -$1.39K | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$891 |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$851 |
